Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03332355
Title Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vanquish Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.